-

JHX ALERT: Kirby McInerney LLP Reminds James Hardie Industries plc Investors of Important Deadline in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE:JHX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Investors have until December 23, 2025 to ask the Court to appoint them as lead plaintiff.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of May 20, 2025 through August 18, 2025, inclusive (“the Class Period”). The lawsuit alleges that James Hardie misled investors about the strength of its key North America Fiber Cement segment between May 20, 2025 and August 18, 2025. Despite knowing by April and early May that distributors were destocking inventory, the Company falsely claimed demand remained strong and that stock levels were normal.

On August 19, 2025, after market hours, James Hardie reported its fiscal Q1 2026 financial results. During the accompanying earnings call, the Company revealed that North American net sales declined 12% during the quarter, driven by lower volumes as customers “made efforts to return to more normal inventory levels.” The Company also revealed that significant inventory destocking among channel partners in North America was expected to continue to impact sales for the next several quarters. On this news, the price of James Hardie shares declined by $9.79 per share, or approximately 34.4%, from $28.43 per share on August 19, 2025 to close at $18.64 on August 20, 2025.

[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]

What Should I Do?

If you purchased or otherwise acquired James Hardie securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[WHAT IS A SECURITIES CLASS ACTION?]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NYSE:JHX

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

HDB INVESTOR ALERT: Securities Class Action Filed Against HDFC Bank Limited – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB) securities during the period of July 17, 2023 through May 26, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the s...

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 30, 2026, Myriad Genetics reported that its second-quarter revenue declined 11% year-...

BANC SHAREHOLDER ALERT: Banc of California, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 29, 2026, Banc of California reported its second quarter 2026 financial results,...
Back to Newsroom